International Biotechnol... Share Discussion Threads

[deadly] 22/6/2017 09:43

Sharp rises these last few days; any fundamental reason?

[its the oxman] 30/4/2017 23:10

Discount has closed slightly. Would be tempted if it widens but not sure that is the way it's going.

[tonytyke2] 21/4/2017 09:12

Happy with the update this morning and still well discounted to NAV. With a chunky dividend yield now, I think I will be adding to my position here.
TT

[steeplejack] 20/2/2017 16:27

Discount now 11% but hitting new highs.Slow and steady I suppose,that's investment trusts for you.

[steeplejack] 10/2/2017 13:28

Remains on a discount of over 10% to NAV.I thought the introduction of a dividend might narrow the discount but it's not to be.

[philo124] 01/2/2017 18:46

Yes, sound bites on tv "news" and threads is come cases haven't reflected the other
side of what he's proposing.

[gilston] 01/2/2017 17:57

Trump is now sounding more balanced on biotech & drugs than before which is helpful.

[philo124] 11/1/2017 16:23

Good wide discount.

[steeplejack] 03/1/2017 10:04

In accordance with this policy, the Directors have today declared an Interim Dividend for the period ended 31 August 2016 in an amount of 11.5p per Ordinary Share.The Interim Dividend will be payable on Tuesday, 31 January 2017 to holders of Ordinary Shares on the Register at the close of business on Friday, 6 January 2017 (ex-dividend Thursday, 5 January 2017).

[steeplejack] 24/11/2016 09:21

Biogen fell sharply yesterday along with Eli Liily off 11% on disappointment about failure of Alzheimer's drug

[philo124] 09/11/2016 15:35

Great rise and BIOG.

[rogerrail] 20/9/2016 12:46

More that double the NAV discount to BIOG. Considering that the share price of each near enough tracks the other is totally nonsensical.

[luckymouse] 20/9/2016 10:35

volatile - but back to 580 looks doable

[tonsil] 18/9/2016 15:08

Good news!! IBT is to pay a 4% divi starting January I believe.

[tonsil] 16/9/2016 13:59

I used to be in this and WWH and Biog but have switched to BB BiotechTrust. It pays a 5% dividend. NAV is about £4 billion from memory and is Swiss based. I still have a small IBT holding. I've not found any negatives on BION (epic) yet. Please post if you dig some up.

[philo124] 16/9/2016 13:29

Quite a NAV discount!

[getscenic] 16/9/2016 12:51

This is where my ARM money is going for sure. Lets hope the vote on divi and un-quoted investments goes through.

[nimbo1] 16/9/2016 12:18

I've been looking at biotech funds for a while now and just took a position here - I think when investors cotton on to the 4.5% divi yield / normal access to growth a fund like this offers the discount will narrow over time.

[steeplejack] 09/9/2016 13:07

"Subject to shareholder approval, the first dividend is expected to be declared in December 2016 and paid in January 2017. The dividend payments should help to further align shareholder interests with portfolio performance"If they pay 4% of NAV,that would equate to a yield of around 4.5% given the discount to asset value.A real attraction and hopefully the perennial discount to NAV will narrow markedly as a result.The move into the unquoted investment arena is mirroring what Woodford has been doing to a lesser extent.Good strategy imo.

[rambutan2] 09/9/2016 12:39

Re today's div proposal rns, relevant nav on link below. So that's 23p total for next company year, 11.5p in Jan and the same in Aug.

[philo124] 03/7/2016 11:12

Holding up well.

[thomasthetank1] 11/5/2016 14:24

Read Edison's note on INTERNATIONAL BIOTECHNOLOGY (IBT), out this morning, by visiting hxxps://www.research-tree.com/company/GB0004559349

"International Biotechnology Trust (IBT) is a long-established specialist fund investing in listed (c 90%) and unlisted (c 10%) companies in the high-growth area of biotechnology. After several years of strong absolute returns, the past six months have seen a sell-off in the sector, arguably sparked more by political pressure and investor risk aversion than by company fundamentals. While a resumption of bull market conditions is uncertain in the near term, the demographic factors and scientific advances underlying innovation..."

[philo124] 08/3/2016 19:30

Back to the days of 15% discount to NAV.

[jimbo55] 13/2/2016 00:32

I would wait for the obvious support level at around £3.20 and then re-evaluate. Looks like a complex head and shoulders top to me, so the decline has further to run if I'm right about this.